Targeting protein-protein interaction interfaces in COVID-19 drug discovery

To date, the COVID-19 pandemic has claimed over 1 million human lives, infected another 50 million individuals and wreaked havoc on the global economy. The crisis has spurred the ongoing development of drugs targeting its etiological agent, the SARS-CoV-2. Targeting relevant protein-protein interact...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chung-ke, Lin, Shan-Meng, Satange, Roshan, Lin, Shih-Chao, Sun, Sin-Cih, Wu, Hung-Yi, Kehn-Hall, Kylene, Hou, Ming-Hon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064971/
https://www.ncbi.nlm.nih.gov/pubmed/33936565
http://dx.doi.org/10.1016/j.csbj.2021.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064971/
https://www.ncbi.nlm.nih.gov/pubmed/33936565
http://dx.doi.org/10.1016/j.csbj.2021.04.003

Ejemplares similares